| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Director | $45M | Nov 12, 2025 | ||
| DSGN | Design Therapeutics, Inc. | President, CEO and Chairperson, Director | Jan 2, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|